CASI Pharmaceuticals, Inc (DE) Quarterly Operating Income (Loss) in USD from Q3 2018 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
CASI Pharmaceuticals, Inc (DE) quarterly/annual Operating Income (Loss) history and growth rate from Q3 2018 to Q4 2022.
  • CASI Pharmaceuticals, Inc (DE) Operating Income (Loss) for the quarter ending December 31, 2022 was -$12.6M, a 14.4% decline year-over-year.
  • CASI Pharmaceuticals, Inc (DE) Operating Income (Loss) for the twelve months ending December 31, 2022 was -$34M, a 18% increase year-over-year.
  • CASI Pharmaceuticals, Inc (DE) annual Operating Income (Loss) for 2022 was -$34M, a 18% increase from 2021.
  • CASI Pharmaceuticals, Inc (DE) annual Operating Income (Loss) for 2021 was -$41.5M, a 21.3% increase from 2020.
  • CASI Pharmaceuticals, Inc (DE) annual Operating Income (Loss) for 2020 was -$52.8M, a 12.4% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 -$34M -$12.6M -$1.59M -14.4% Oct 1, 2022 Dec 31, 2022 20-F 2023-04-26
Q3 2022 -$32.4M -$6.35M +$538K +7.81% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$33M -$7.75M +$232K +2.91% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 -$33.2M -$7.29M +$8.31M +53.3% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 -$41.5M -$11M +$5.41M +32.9% Oct 1, 2021 Dec 31, 2021 20-F 2023-04-26
Q3 2021 -$46.9M -$6.89M +$11.8M +63.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$58.7M -$7.98M +$909K +10.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$59.6M -$15.6M -$6.83M -77.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$52.8M -$16.5M -$4.28M -35.2% Oct 1, 2020 Dec 31, 2020 20-F 2023-04-26
Q3 2020 -$48.5M -$18.7M -$8.02M -75.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$40.5M -$8.89M +$6.92M +43.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$47.4M -$8.77M -$446K -5.36% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$47M -$12.2M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 -$10.6M -$1.93M -22.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$15.8M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$8.33M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q3 2018 -$8.71M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.